Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 4
2014 3
2015 6
2016 3
2017 4
2018 4
2019 9
2020 10
2021 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Black and Pink: Single Lesion or Double Diagnosis?
Proietti I, Di Fraia M, Michelini S, Colapietra D, Rullo E, Porta N, Petrozza V, Skroza N, Potenza C. Proietti I, et al. Among authors: porta n. Dermatol Pract Concept. 2019 Dec 31;10(1):e2020025. doi: 10.5826/dpc.1001a25. eCollection 2020. Dermatol Pract Concept. 2019. PMID: 31921512 Free PMC article. No abstract available.
Ingenol mebutate therapy in erythroplasia of Queyrat: a new approach.
Proietti I, Michelini S, Skroza N, Bernardini N, Tolino E, Anzalone A, Colapietra D, Mambrin A, DI Fraia M, Marchesiello A, Balduzzi V, Porta N, Petrozza V, Potenza C. Proietti I, et al. Among authors: porta n. Ital J Dermatol Venerol. 2021 Jun;156(3):388-391. doi: 10.23736/S2784-8671.19.06371-5. Epub 2019 Dec 4. Ital J Dermatol Venerol. 2021. PMID: 31804047
Metastatic penile squamous cell carcinoma successfully treated with cemiplimab in an HIV patient.
Proietti I, Skroza N, Filippi L, Balduzzi V, Michelini S, Bagni O, Bernardini N, Maddalena P, Mambrin A, Marchesiello A, Tolino E, Volpe S, Lichtner M, Porta N, Petrozza V, Potenza C. Proietti I, et al. Among authors: porta n. Dermatol Ther. 2021 Mar;34(2):e14744. doi: 10.1111/dth.14744. Epub 2021 Jan 17. Dermatol Ther. 2021. PMID: 33405367 No abstract available.
Melanoma: Double BRAF mutation, double chance to treat?
Proietti I, Michelini S, Skroza N, Mambrin A, Tolino E, Bernardini N, Di Fraia M, Balduzzi V, Marchesiello A, Volpe S, Maddalena P, Calogero A, Romeo G, Porta N, Pacini L, Di Cristofano C, Petrozza V, Potenza C. Proietti I, et al. Among authors: porta n. Dermatol Ther. 2020 Nov;33(6):e13820. doi: 10.1111/dth.13820. Epub 2020 Jul 6. Dermatol Ther. 2020. PMID: 32530551 No abstract available.
Argonaute 2 drives miR-145-5p-dependent gene expression program in breast cancer cells.
Bellissimo T, Tito C, Ganci F, Sacconi A, Masciarelli S, Di Martino G, Porta N, Cirenza M, Sorci M, De Angelis L, Rosa P, Calogero A, Fatica A, Petrozza V, Fontemaggi G, Blandino G, Fazi F. Bellissimo T, et al. Among authors: porta n. Cell Death Dis. 2019 Jan 8;10(1):17. doi: 10.1038/s41419-018-1267-5. Cell Death Dis. 2019. PMID: 30622242 Free PMC article.
Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality.
Sanese P, Fasano C, Buscemi G, Bottino C, Corbetta S, Fabini E, Silvestri V, Valentini V, Disciglio V, Forte G, Lepore Signorile M, De Marco K, Bertora S, Grossi V, Guven U, Porta N, Di Maio V, Manoni E, Giannelli G, Bartolini M, Del Rio A, Caretti G, Ottini L, Simone C. Sanese P, et al. Among authors: porta n. iScience. 2020 Oct 7;23(10):101604. doi: 10.1016/j.isci.2020.101604. eCollection 2020 Oct 23. iScience. 2020. PMID: 33205017 Free PMC article.
Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma.
Petrozza V, Carbone A, Bellissimo T, Porta N, Palleschi G, Pastore AL, Di Carlo A, Della Rocca C, Fazi F. Petrozza V, et al. Among authors: porta n. Int J Mol Sci. 2015 Dec 8;16(12):29219-25. doi: 10.3390/ijms161226160. Int J Mol Sci. 2015. PMID: 26670229 Free PMC article.
40 results